Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis
Authors
Keywords
Colorectal, Cancer, Biomarker, ctDNA
Journal
EUROPEAN JOURNAL OF CANCER
Volume 144, Issue -, Pages 368-381
Publisher
Elsevier BV
Online
2021-01-09
DOI
10.1016/j.ejca.2020.11.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial
- (2020) John A Bridgewater et al. LANCET ONCOLOGY
- Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges
- (2020) Koncina et al. Cancers
- A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone for liver metastasis from colorectal cancer: JCOG0603 study.
- (2020) Yukihide Kanemitsu et al. JOURNAL OF CLINICAL ONCOLOGY
- ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
- (2020) Arvind Dasari et al. Nature Reviews Clinical Oncology
- Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer
- (2019) Raja R. Narayan et al. ANNALS OF SURGICAL ONCOLOGY
- Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
- (2019) Ning Jia et al. Frontiers in Genetics
- Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
- (2019) Bidard et al. Cells
- Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS ‐mutant metastatic colorectal cancer
- (2019) Elena Elez et al. Molecular Oncology
- Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancer
- (2019) Iben Lyskjær et al. Scientific Reports
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- Impact of Emergent Circulating Tumor DNARASMutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer
- (2018) Tae Won Kim et al. CLINICAL CANCER RESEARCH
- Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma
- (2018) C. B. Thomsen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
- (2018) Hung-Chih Hsu et al. MOLECULAR CANCER THERAPEUTICS
- Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
- (2018) Caroline Vandeputte et al. Oncotarget
- Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis
- (2018) Jagdeep Singh Bhangu et al. ANNALS OF SURGERY
- Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study
- (2018) Marc Peeters et al. CLINICAL CANCER RESEARCH
- Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study
- (2017) Khurum Khan et al. GUT
- Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
- (2017) Ludovic Barault et al. GUT
- Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients
- (2017) Masami Yamauchi et al. INTERNATIONAL JOURNAL OF CANCER
- Methylated free-circulatingHPP1DNA is an early response marker in patients with metastatic colorectal cancer
- (2017) Andreas Herbst et al. INTERNATIONAL JOURNAL OF CANCER
- Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients
- (2017) Chiara Bedin et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
- (2016) S. El Messaoudi et al. CLINICAL CANCER RESEARCH
- A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
- (2016) S. Garrigou et al. CLINICAL CHEMISTRY
- The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator
- (2015) N. Ayez et al. EJSO
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
- (2015) Thomas Reinert et al. GUT
- Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
- (2014) John Primrose et al. LANCET ONCOLOGY
- Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
- (2013) Bernard Nordlinger et al. LANCET ONCOLOGY
- Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)
- (2012) Halfdan Sorbye et al. ANNALS OF SURGERY
- Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases
- (2012) R. P. Jones et al. BRITISH JOURNAL OF SURGERY
- Prognostic role of methylated free circulating DNA in colorectal cancer
- (2012) Alexander B. Philipp et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer
- (2010) Benoit Lefebure et al. ANNALS OF SURGERY
- A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
- (2009) M. Ychou et al. ANNALS OF ONCOLOGY
- Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
- (2008) Emmanuel Mitry et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now